Analgesic Efficacy of Maxigesic Added to Opioid Based-PCA in Patients Undergoing Breast Cancer Surgery
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The present study aims to find a perioperative analgesic method that provides sufficient analgesia while reducing immune compromise in cancer surgery. This study is to investigate the analgesic effect and safety of Maxigesic inj. (a combination of acetaminophen 1000 mg and ibuprofen 300 mg), which is added to opioid-based IV-PCA in patients undergoing breast cancer surgery.
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 20
Maximum Age: 70
Healthy Volunteers: f
View:
• Patient aged 20 to 70 years with ASA classification 1 to 3 undergoing breast cancer surgery (cancer resection or reconstruction)
Locations
Other Locations
Republic of Korea
Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine
RECRUITING
Seoul
Contact Information
Primary
Jin Sun Cho
chjs0214@yuhs.ac
82-2-2228-2419
Time Frame
Start Date: 2023-12-28
Estimated Completion Date: 2025-12-26
Participants
Target number of participants: 84
Treatments
Placebo_comparator: Study group
Group administered Maxigesic solution
Experimental: Control group
Group administerd 0.9% saline solution
Related Therapeutic Areas
Sponsors
Leads: Yonsei University